What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?

Béatrice Desnous(Inserm), Ala Birca(Centre Hospitalier Universitaire Sainte-Justine), Nathalie Villeneuve(Henri Gastaut Hospital), Mélina Arbour(Centre Hospitalier Universitaire Sainte-Justine), Jonathan Bitton(Centre Hospitalier Universitaire Sainte-Justine), I Mohammed(University of Alabama at Birmingham), Marien Lenoir(Université de Montréal), Anne Lortie, Gabriel M. Ronen(McMaster University), Elaine Wirrell(WinnMed), Luis Bello‐Espinosa(University of Calgary), Sharon Whiting(Children's Hospital of Eastern Ontario)
Seizure
August 2, 2021
10.1016/j.seizure.2021.07.032
Cited by 3

Related Papers

Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group
|Epilepsia|2008|603
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
|Nature Genetics|2010|509
Diagnosis delay in West syndrome: misdiagnosis and consequences
|European Journal of Pediatrics|2012|88
Molecular and clinical descriptions of patients with <scp>GABA<sub>A</sub></scp> receptor gene variants (<i><scp>GABRA1</scp>, <scp>GABRB2</scp>, <scp>GABRB3</scp>, <scp>GABRG2</scp></i>): A cohort study, review of literature, and genotype–phenotype correlation
|Epilepsia|2022|80
LGI1 and CASPR2 neurological autoimmunity in children
|Annals of Neurology|2018|74